5-fluorodihydrouracil has been researched along with Dihydropyrimidine Dehydrogenase Deficiency in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akın, O; Cihan, M; Serdar, MA; Sertoğlu, E; Tapan, S; Uyanık, M | 1 |
de Vries, EG; Greijdanus, B; Maring, JG; Schouten, L; Uges, DR | 1 |
2 other study(ies) available for 5-fluorodihydrouracil and Dihydropyrimidine Dehydrogenase Deficiency
Article | Year |
---|---|
Determination of 5-fluorouracil and dihydrofluorouracil levels by using a liquid chromatography-tandem mass spectrometry method for evaluation of dihydropyrimidine dehydrogenase enzyme activity.
Topics: Antimetabolites, Antineoplastic; Biotransformation; Chromatography, High Pressure Liquid; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Drug Monitoring; Enzyme Assays; Fluorouracil; Humans; Kinetics; Leukocytes, Mononuclear; Limit of Detection; Neoplasms; Precision Medicine; Reproducibility of Results; Severity of Illness Index; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2011 |
A simple and sensitive fully validated HPLC-UV method for the determination of 5-fluorouracil and its metabolite 5,6-dihydrofluorouracil in plasma.
Topics: Chromatography, High Pressure Liquid; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Drug Monitoring; Fluorouracil; Humans; Spectrophotometry, Ultraviolet | 2005 |